Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
36.06
-0.07 (-0.19%)
Feb 23, 2026, 10:44 AM EST - Market open
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
US Revenue | 3.26B | 3.12B | 2.98B | |||||||||||
US Revenue Growth | 4.26% | 4.83% | 7.78% | |||||||||||
Other Established Markets Revenue | 1.80B | 1.71B | 1.61B | |||||||||||
Other Established Markets Revenue Growth | 5.27% | 5.96% | 7.11% | |||||||||||
Total Established Markets Revenue | 5.05B | 4.83B | 4.59B | |||||||||||
Total Established Markets Revenue Growth | 4.62% | 5.23% | 7.54% | |||||||||||
Emerging Markets Revenue | 979.00M | 980.00M | 959.00M | |||||||||||
Emerging Markets Revenue Growth | -0.10% | 2.19% | 1.27% | |||||||||||
Revenue (Total) | - | 5.81B | 5.55B | |||||||||||
Revenue (Total) Growth | - | 4.70% | 6.40% |
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Knee Implants Revenue | 982.00M | 947.00M | 940.00M | |||||||||||
Knee Implants Revenue Growth | 3.70% | 0.74% | 4.56% | |||||||||||
Hip Implants Revenue | 628.00M | 619.00M | 599.00M | |||||||||||
Hip Implants Revenue Growth | 1.45% | 3.34% | 2.57% | |||||||||||
Other Reconstruction Revenue | 132.00M | 131.00M | 111.00M | |||||||||||
Other Reconstruction Revenue Growth | 0.76% | 18.02% | 27.59% | |||||||||||
Trauma & Extremities Revenue | 636.00M | 608.00M | 564.00M | |||||||||||
Trauma & Extremities Revenue Growth | 4.61% | 7.80% | 3.87% | |||||||||||
Total Orthopaedics Revenue | 2.38B | 2.31B | 2.21B | |||||||||||
Total Orthopaedics Revenue Growth | 3.17% | 4.11% | 4.78% | |||||||||||
Sports Medicine Joint Repair Revenue | 1.03B | 982.00M | 945.00M | |||||||||||
Sports Medicine Joint Repair Revenue Growth | 4.99% | 3.91% | 8.62% | |||||||||||
Arthroscopic Enabling Technologies Revenue | 637.00M | 632.00M | 588.00M | |||||||||||
Arthroscopic Enabling Technologies Revenue Growth | 0.79% | 7.48% | 3.70% | |||||||||||
ENT (Ear, Nose and Throat) Revenue | 218.00M | 210.00M | 196.00M | |||||||||||
ENT (Ear, Nose and Throat) Revenue Growth | 3.81% | 7.14% | 28.11% | |||||||||||
Total Sports Medicine & ENT Revenue | 1.89B | 1.82B | 1.73B | |||||||||||
Total Sports Medicine & ENT Revenue Growth | 3.40% | 5.50% | 8.74% | |||||||||||
Advanced Wound Care Revenue | 749.00M | 735.00M | 725.00M | |||||||||||
Advanced Wound Care Revenue Growth | 1.91% | 1.38% | 1.83% | |||||||||||
Advanced Wound Bioactives Revenue | 622.00M | 581.00M | 553.00M | |||||||||||
Advanced Wound Bioactives Revenue Growth | 7.06% | 5.06% | 6.35% | |||||||||||
Advanced Wound Devices Revenue | 397.00M | 365.00M | 328.00M | |||||||||||
Advanced Wound Devices Revenue Growth | 8.77% | 11.28% | 17.14% | |||||||||||
Total Advanced Wound Management Revenue | 1.77B | 1.68B | 1.61B | |||||||||||
Total Advanced Wound Management Revenue Growth | 5.17% | 4.67% | 6.22% | |||||||||||
Revenue (Total) | - | 5.81B | 5.55B | |||||||||||
Revenue (Total) Growth | - | 4.70% | 6.40% |
Adjusted EBIT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Orthopaedics Segment Profit | 265.00M | 251.00M | |||||||||||
Orthopaedics Segment Profit Growth | 5.58% | -34.47% | |||||||||||
Sports Medicine & ENT Segment Profit | 437.00M | 394.00M | |||||||||||
Sports Medicine & ENT Segment Profit Growth | 10.91% | -16.53% | |||||||||||
Advanced Wound Management Segment Profit | 399.00M | 372.00M | |||||||||||
Advanced Wound Management Segment Profit Growth | 7.26% | -14.68% | |||||||||||
Operating Income (Other) | -444.00M | -592.00M | |||||||||||
Operating Income (Total) | 657.00M | 425.00M | |||||||||||
Operating Income (Total) Growth | 54.59% | -5.56% |
Updated Sep 27, 2025. Data Source: Fiscal.ai.